Autor: Virginia E. Wotring
ISBN-13: 9781461433958
Einband: Book
Seiten: 109
Format: 239x159x12 mm
Sprache: Englisch

Space Pharmacology

SpringerBriefs in Space Development
In den Warenkorb
58,84 €
Presents the practice and problems associated with the use of pharmaceuticals in the extreme environment of spaceflight
Chapter 1: Introduction.- Chapter 2: Absorption.- Chapter 3: Distribution.- Chapter 4: Metabolism and Excretion.- Chapter 5: Central Nervous System.- Chapter 6: Cardiovascular System.- Chapter 7: Gastrointestinal System.- Chapter 8: Musculoskeletal System.- Chapter 9: Multiple Systems Spaceflight Effects.- Chapter 10: Conclusions - Special Challenges of Long Duration Exploration.- References.- Abbreviations.
"Space Pharmacology" is a review of the current knowledge regarding the use of pharmaceuticals during spaceflights. It is a comprehensive review of the literature, addressing each area of pharmacokinetics and each major physiological system in turn. Every section begins with a topic overview, and is followed by a discussion of published data from spaceflight, and from ground experiments meant to model the spaceflight situation. Includes a discussion looking forward to the new medical challenges we are likely to face on longer duration exploration missions. This book is a snapshot of our current knowledge that also highlights areas of unknown.
Autor: Virginia E. Wotring
Dr. Virginia Wotring is a Senior Scientist in the Division of Space Life Sciences at Universities Space Research Association, and Pharmacology Discipline Lead at NASA's Johnson Space Center, Human Health and Countermeasures. She received her doctorate in Pharmacological and Physiological Sciences at Saint Louis University after earning a BS in Chemistry at Florida State University. She has extensive experience studying drug mechanisms of action, drug receptor structure/function relationships, and gene and protein expression.
In 2009, she began directing the NASA JSC Pharmacology Lab, whose mission is to ensure that medications used during spaceflight will act in a predictable, effective and safe manner. The spaceflight environment includes several unusual stressors for the body: microgravity, fluid shifting, increased radiation exposure, lack of circadian cues and others. Each of these can alter normal physiology, and thus, change the way in which drugs are absorbed, distributed, metabolized, excreted or how they interact with physiological targets. Current projects include: determining cardiac safety of new and experimental anti-motion sickness combination therapies, and measurement of gene and protein expression after exposure to spaceflight or a gamma radiation analog of spaceflight.
Dr. Wotring is also actively involved in mentoring students and interns, and participates in teaching at area universities. She holds adjunct appointments in the UTMB Galveston Department of Pharmacology and Toxicology and at the University of Houston's Department of Health and Human Performance.

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.



Autor: Virginia E. Wotring
ISBN-13:: 9781461433958
ISBN: 1461433959
Erscheinungsjahr: 18.03.2012
Verlag: Springer-Verlag GmbH
Gewicht: 198g
Seiten: 109
Sprache: Englisch
Sonstiges: Taschenbuch, 239x159x12 mm, 14 schwarz-weiße und 6 farbige Abbildungen, 4 schwarz-weiße Tabellen